Glenmark Pharmaceuticals Inc., USA launches Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL)
MAHWAH, N.J., Feb. 14, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce the launch1 of Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL). Glenmark's Latanoprost Ophthalmic Solution, 0.005%